BiomX Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2016
Selling, General & Admin	14.79	9.56	10.56	12.28	9.99	Upgrade
Research & Development	20.76	15.79	15.14	21.67	18.75	Upgrade
Operating Expenses	35.55	25.35	27.22	35.46	30.26	Upgrade
Operating Income	-35.55	-25.35	-27.22	-35.46	-30.26	Upgrade
Interest Expense	-0.87	-2.4	-2.07	-0.7	-	Upgrade
Interest & Investment Income	1.05	1.12	0.46	0.09	0.64	Upgrade
Currency Exchange Gain (Loss)	-0.05	0.18	0.45	-0.08	-0.35	Upgrade
Other Non Operating Income (Expenses)	24.71	0.3	0.12	-0.01	-0.01	Upgrade
EBT Excluding Unusual Items	-10.72	-26.15	-28.25	-36.16	-29.97	Upgrade
Merger & Restructuring Charges	-0.89	-	-	-	-	Upgrade
Impairment of Goodwill	-0.8	-	-	-	-	Upgrade
Asset Writedown	-4.05	-	-	-	-	Upgrade
Other Unusual Items	1.98	-	-	-	-0.12	Upgrade
Pretax Income	-17.71	-26.15	-28.25	-36.16	-30.09	Upgrade
Income Tax Expense	0.01	0.02	0.07	0.07	-	Upgrade
Net Income	-17.73	-26.17	-28.32	-36.23	-30.09	Upgrade
Net Income to Common	-17.73	-26.17	-28.32	-36.23	-30.09	Upgrade
Shares Outstanding (Basic)	12	5	3	3	2	Upgrade
Shares Outstanding (Diluted)	13	5	3	3	2	Upgrade
Shares Change (YoY)	155.95%	71.94%	14.79%	12.77%	310.66%	Upgrade
EPS (Basic)	-1.47	-5.10	-9.49	-13.93	-13.05	Upgrade
EPS (Diluted)	-3.36	-5.10	-9.49	-13.93	-13.05	Upgrade
Free Cash Flow	-37.01	-21.34	-29.2	-31.26	-25.46	Upgrade
Free Cash Flow Per Share	-2.82	-4.16	-9.78	-12.02	-11.04	Upgrade
EBITDA	-33.75	-24.48	-26.22	-34.42	-29.6	Upgrade
D&A For EBITDA	1.8	0.87	1	1.05	0.66	Upgrade
EBIT	-35.55	-25.35	-27.22	-35.46	-30.26	Upgrade

Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q